Rhofade Cream
Product Images NDC 71403-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Rhofade (NDC 71403-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epi Health, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rhofade 01)

FDA Label Image

Image (Rhofade 02)

FDA Label Image

Image (Rhofade 03)

FDA Label Image

Image (Rhofade 04)

FDA Label Image

Image (Rhofade 05)

FDA Label Image

Image (Rhofade 06)

FDA Label Image

Image (Rhofade 07)

FDA Label Image

Image (Rhofade 08)

FDA Label Image

Image (Rhofade 09)

FDA Label Image

Image (Rhofade 10)

FDA Label Image

Principal Display Panel (30 g Tube Carton)

Principal Display Panel (30 g Tube Carton)
This appears to be a product description. The product is named FHOFADE® cream and is intended for topical use only. It contains clametazine, axymetezciine hydrochloride, and other inactive ingredients. The product comes in a tub and can be applied to the forehead, nose, chin, and around the eyes and lips. Each gram of the cream contains 10mg of axymetezciine hydrochloride (1%). The package should be stored at 20°C-25°C, with excursions permitted to 15°C-30°C. The dosage should be a pea-sized amount of cream applied to the desired areas.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.